Philips vs Lam Research
Side-by-side comparison of AI visibility scores, market position, and capabilities
Dutch health technology company with €17B revenue; MRI/CT imaging and patient monitoring managing massive sleep apnea device recall competing with Siemens Healthineers and GE HealthCare.
About
Philips is a Dutch multinational technology and health technology company that has transformed from a broad consumer electronics conglomerate into a focused health technology leader — producing diagnostic imaging systems (MRI, CT, ultrasound), patient monitoring, hospital informatics, personal health products (electric toothbrushes, shavers, sleep apnea devices), and health informatics solutions. Listed on the Amsterdam Stock Exchange (AEX: PHIA) and headquartered in Amsterdam, Philips generates approximately €17 billion ($18 billion) in annual revenue after divesting its lighting division (now Signify) and domestic appliances business.\n\nPhilips' health technology portfolio spans two segments: Diagnosis & Treatment (imaging systems, image-guided therapy, and ultrasound for hospitals) and Connected Care (patient monitoring, respiratory care, sleep therapy). The Diagnosis & Treatment segment provides MRI systems, CT scanners, and X-ray equipment to hospitals globally. The Connected Care segment includes Philips' DreamStation and other sleep apnea (CPAP/BiPAP) devices, home respiratory care, and hospital patient monitoring platforms.\n\nIn 2025, Philips is managing the severe consequences of a 2021 recall of approximately 5.5 million sleep apnea devices (Philips Respironics DreamStation and related models) due to concerns that degraded polyester foam could release harmful particles and gases — one of the largest medical device recalls in history. The recall has resulted in multi-billion dollar settlements, regulatory scrutiny, and significant reputation damage in the sleep therapy market, allowing competitors ResMed and Fisher & Paykel to gain share. Philips' 2025 strategy focuses on resolving recall liabilities, rebuilding the sleep therapy business, and investing in AI-powered diagnostic imaging to compete with Siemens Healthineers and GE HealthCare.
Fremont CA semiconductor etch and deposition (NASDAQ: LRCX) $14.9B FY2024 revenue; 3D NAND/HBM etch leader, 40%+ plasma etch share, $5B+ services revenue competing with Applied Materials and Tokyo Electron.
About
Lam Research Corporation is a Fremont, California-based semiconductor equipment company — publicly traded on the NASDAQ (NASDAQ: LRCX) as an S&P 500 Information Technology component — designing and manufacturing etch and deposition systems critical for semiconductor chip fabrication, providing products across plasma etch (removing material layers with precision), chemical vapor deposition (CVD — depositing thin films on wafers), atomic layer deposition (ALD — depositing single atomic layers with Angstrom-level precision), and related services through approximately 17,000 employees worldwide. In fiscal year 2024 (ending June 2024), Lam Research reported revenues of $14.9 billion, with strong revenue recovery driven by semiconductor industry capex expansion (NAND flash memory producers resuming equipment orders after the 2022-2023 memory market downturn, and DRAM producers expanding capacity for HBM — High Bandwidth Memory — required in NVIDIA AI GPU packages). CEO Tim Archer has positioned Lam Research as an "advanced process technology" partner rather than a pure equipment vendor: Lam's ALD-Select, VECTOR deposition, and Kiyo etch systems are co-developed with leading chipmakers (TSMC, Samsung, SK Hynix, Micron) for specific process nodes — creating application-specific systems optimized for 3nm logic, 1-alpha DRAM, and 200+ layer 3D NAND that require Lam's process understanding rather than generic equipment. Lam Research's Global Customer Support (GCS) organization provides equipment maintenance, spare parts, and process consulting services — generating $5+ billion annually in recurring service revenue that is less cyclical than equipment capital expenditure.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.